High plasma 25‐hydroxyvitamin D and high risk of nonmelanoma skin cancer: a Mendelian randomization study of 97 849 individuals

High plasma 25‐hydroxyvitamin D [25(OH)D] concentration has been associated observationally with a high risk of nonmelanoma skin cancer (NMSC), whereas many studies suggest that vitamin D could have a protective effect against cancer. The true association between vitamin D and risk of skin cancer remains unclear.

[1]  J. Wetterslev,et al.  Vitamin D supplementation for prevention of cancer in adults. , 2014, The Cochrane database of systematic reviews.

[2]  Ishir Bhan,et al.  Vitamin D-binding protein and vitamin D status of black Americans and white Americans. , 2013, The New England journal of medicine.

[3]  S. Bojesen,et al.  Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. , 2013, Clinical chemistry.

[4]  S. Bojesen,et al.  Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study. , 2013, The Journal of investigative dermatology.

[5]  A. Green,et al.  Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community. , 2013, The Journal of investigative dermatology.

[6]  P. McKeigue,et al.  Instrumental Variable Estimation of the Causal Effect of Plasma 25-Hydroxy-Vitamin D on Colorectal Cancer Risk: A Mendelian Randomization Analysis , 2012, PloS one.

[7]  H. Nan,et al.  Pre-Diagnostic Plasma 25-Hydroxyvitamin D Levels and Risk of Non-Melanoma Skin Cancer in Women , 2012, PloS one.

[8]  D. Rao,et al.  Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort. , 2011, Archives of dermatology.

[9]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Marianne Lundkjær Gjerstorff,et al.  The Danish Cancer Registry , 2011, Scandinavian journal of public health.

[11]  Daniel L. Koller,et al.  Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2010, The Lancet.

[12]  Jianhua Zhang,et al.  Identification of two distinct cell binding sequences in the vitamin D binding protein. , 2010, Biochimica et biophysica acta.

[13]  M. Chren,et al.  Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. , 2010, The Journal of investigative dermatology.

[14]  William Wheeler,et al.  Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.

[15]  R. Jorde,et al.  Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. , 2010, American journal of epidemiology.

[16]  M. Chren,et al.  Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men , 2009, Cancer Causes & Control.

[17]  P. Goodwin,et al.  Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  W. Willett,et al.  A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. , 2007, Journal of the National Cancer Institute.

[19]  W. Willett,et al.  Vitamin D Intake and the Risk for Pancreatic Cancer in Two Cohort Studies , 2006, Cancer Epidemiology Biomarkers & Prevention.

[20]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[21]  Edward Giovannucci,et al.  Vitamin D and prevention of colorectal cancer , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  Toshio Okano,et al.  22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. , 2005, Carcinogenesis.

[23]  D. Rao,et al.  Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. , 2004, Clinical biochemistry.

[24]  S. Kato,et al.  1α, 25-Dihydroxyvitamin D3 is a preventive factor in the metastasis of lung cancer , 2004 .

[25]  S. Hankinson,et al.  Plasma vitamin D metabolites and risk of colorectal cancer in women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  Roberto Dominguez,et al.  Crystal structures of the vitamin D-binding protein and its complex with actin: Structural basis of the actin-scavenger system , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Xuening Wang,et al.  Activation of extracellular signal‐regulated kinases (ERKs) defines the first phase of 1,25‐dihydroxyvitamin D3‐induced differentiation of HL60 cells , 2001, Journal of cellular biochemistry.

[28]  M. Hakama,et al.  Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) , 2000, Cancer Causes & Control.

[29]  N. Bundred,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Angiogenesis In Vitro and In Vivo , 2000 .

[30]  M. Demay,et al.  Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. , 2000, Endocrinology.

[31]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[32]  H. Storm,et al.  The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.

[33]  M. Young,et al.  Inhibition of tumor invasiveness by 1-alpha-25-dihydroxy-vitamin D coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization , 1997, Clinical & Experimental Metastasis.

[34]  J. Welsh,et al.  1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  K. Helzlsouer,et al.  Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. , 1995, American journal of epidemiology.

[36]  D. Kromhout,et al.  Stability of blood (pro)vitamins during four years of storage at −20 °C: Consequences for epidemiologic research , 1995 .

[37]  M. Rizk-Rabin,et al.  Synthesis of and response to 1,25 dihydroxycholecalciferol by subpopulations of murine epidermal keratinocytes: Existence of a paracrine system for 1,25 dihydroxycholecalciferol , 1994, Journal of cellular physiology.

[38]  C. Garland,et al.  SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDY , 1989, The Lancet.

[39]  J. Sutherland,et al.  Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Storm,et al.  Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. , 1988, International journal of epidemiology.

[41]  R. Anderson,et al.  Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. , 1982, Science.

[42]  J. Parrish,et al.  Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. , 1982, The New England journal of medicine.

[43]  D. Feldman,et al.  1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. , 1981, Endocrinology.

[44]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[45]  J. Frommer,et al.  Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. , 1977, Biochemical and biophysical research communications.

[46]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[47]  E. Takeda,et al.  1a,25-Dihydroxyvitamin D3 is a preventive factor in the metastasis of lung cancer , 2005 .

[48]  D. Thurnher,et al.  1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. , 2001, Acta oto-laryngologica.

[49]  D. Kromhout,et al.  Stability of blood (pro)vitamins during four years of storage at -20 degrees C: consequences for epidemiologic research. , 1995, Journal of clinical epidemiology.

[50]  H. Storm.  The Danish Cancer Registry, a self-reporting national cancer registration system with elements of active data collection. , 1991, IARC scientific publications.

[51]  J. Eisman,et al.  Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. , 1987, Cancer research.